174 related articles for article (PubMed ID: 33580628)
1. Effect of chemotherapy on survival in patients with stage T3-4N0M0 nasopharyngeal carcinoma.
Pan XB; Qu S; Li L; Chen L; Liang SX; Zhu XD
Clin Otolaryngol; 2021 Jul; 46(4):802-808. PubMed ID: 33580628
[TBL] [Abstract][Full Text] [Related]
2. Significance of chemotherapy for older patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A propensity score matching analysis.
Chen J; Ding J; Xu Y; Hong H; Lin X; Xu M; Yan L; Xu T; Fei Z; Chen C
J Geriatr Oncol; 2023 Nov; 14(8):101648. PubMed ID: 37897887
[TBL] [Abstract][Full Text] [Related]
3. Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.
Wang L; Wu Z; Xie D; Lv S; Xia L; Su Y
Radiat Oncol; 2020 Jul; 15(1):160. PubMed ID: 32615984
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it.
Qu W; Wang X; Qiao Q; Wang Y
Cancer Med; 2023 Mar; 12(6):6994-7004. PubMed ID: 36494918
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma.
Ma JL; Huang ST; Jiang YM; Pan XB
Front Oncol; 2021; 11():735817. PubMed ID: 34722284
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of chemotherapy in survival of stage II nasopharyngeal carcinoma.
Pan XB; Li L; Qu S; Chen L; Liang SX; Zhu XD
Oral Oncol; 2020 Feb; 101():104520. PubMed ID: 31841883
[TBL] [Abstract][Full Text] [Related]
7. Retropharyngeal lymph node metastasis on N stage of nasopharyngeal carcinoma.
Pan XB; Huang ST; Qu S; Chen KH; Jiang YM; Zhu XD
PLoS One; 2021; 16(6):e0253424. PubMed ID: 34138943
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of chemoradiotherapy versus radiotherapy alone in patients with intermediate-risk nasopharyngeal carcinoma: a population-based analysis.
Xu YC; Chen KH; Liang ZG; Zhu XD
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1793-1802. PubMed ID: 36335249
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of chemoradiotherapy in survival of stage Ⅳ nasopharyngeal carcinoma and establishment of a prognostic model.
Luo HD; Xia FJ; Wu JH; Yi B
Oral Oncol; 2022 Aug; 131():105927. PubMed ID: 35679694
[TBL] [Abstract][Full Text] [Related]
10. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
Pan XX; Liu YJ; Yang W; Chen YF; Tang WB; Li CR
Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy in local-regionally advanced nasopharyngeal carcinoma: A National Cancer Database analysis.
Tam M; Lee A; Wu SP; Gerber NK; Li Z; Givi B; Hu K; Schreiber D
Laryngoscope; 2018 Dec; 128(12):2770-2777. PubMed ID: 30133799
[TBL] [Abstract][Full Text] [Related]
12. Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study.
Liu DH; Zhou XY; Pan YG; Chen S; Ye ZH; Chen GD
Cancer Med; 2020 Feb; 9(4):1287-1297. PubMed ID: 31859464
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio before Radical Radiotherapy in Patients with Non-metastatic Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis.
Kim JS; Keam B; Heo DS; Han DH; Rhee CS; Kim JH; Jung KC; Wu HG
Cancer Res Treat; 2019 Oct; 51(4):1313-1323. PubMed ID: 30699498
[TBL] [Abstract][Full Text] [Related]
14. Metastatic Patterns and Prognosis of de novo Metastatic Nasopharyngeal Carcinoma in the United States.
Xu Y; Huang T; Mao M; Zhai J; Chen J
Laryngoscope; 2021 Apr; 131(4):E1130-E1138. PubMed ID: 32833262
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC
Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508
[TBL] [Abstract][Full Text] [Related]
16. Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.
Xu C; Sun R; Tang LL; Chen L; Li WF; Mao YP; Zhou GQ; Guo R; Lin AH; Sun Y; Ma J; Hu WH
Oral Oncol; 2018 Mar; 78():37-45. PubMed ID: 29496056
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X
Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and survival outcomes of ascending, descending and mixed types of nasopharyngeal carcinoma in the non-endemic areas of china: A propensity score matching analysis.
Fan Y; Guan W; Huang R; Lin SY; Song Y; Lu S; Kang L; Yang Q; Lang J; Zhang P
Cancer Med; 2020 Dec; 9(24):9315-9325. PubMed ID: 33058559
[TBL] [Abstract][Full Text] [Related]
20. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]